What is APPCO Pharma?
Headquartered in Somerset and Piscataway, New Jersey, APPCO Pharma operates as a specialized developer and manufacturer of high-quality, affordable generic medications. By focusing on therapeutic equivalents to brand-name pharmaceuticals, the company addresses critical gaps in healthcare accessibility. Its facilities are engineered to support the entire product lifecycle, ranging from initial conception and formulation to full-scale commercialization of solid oral dosage forms. This end-to-end capability positions APPCO Pharma as a reliable partner in the global supply chain for cost-effective medical solutions.
How much funding has APPCO Pharma raised?
APPCO Pharma has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in APPCO Pharma
PPP
Public-Private Partnership
What's next for APPCO Pharma?
The infusion of capital is expected to accelerate the company's strategic roadmap, particularly regarding the expansion of its manufacturing footprint and the diversification of its generic drug portfolio. As the pharmaceutical industry faces increasing pressure to lower costs while maintaining rigorous quality standards, APPCO Pharma is well-positioned to leverage its current financial backing to enhance its R&D throughput. Future growth will likely center on optimizing supply chain efficiencies and navigating the complex regulatory environment to bring more affordable alternatives to market, thereby strengthening its competitive advantage in the enterprise-level pharmaceutical space.
See full APPCO Pharma company page
